Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Gene Expression Market, By Process Type
7.1. Gene Expression Market, by Process Type, 2020-2030
7.1.1. Sample Collection
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Purification
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. cDNA Synthesis & Conversion
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. PCR Analysis
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Data Analysis & Interpretation
7.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Gene Expression Market, By Product Type
8.1. Gene Expression Market, by Product Type, 2020-2030
8.1.1. Kits & Reagents
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. DNA Chip/Microarray
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Gene Expression Market, By Capacity Type
9.1. Gene Expression Market, by Capacity Type, 2020-2030
9.1.1. Low- to Mid-Plex
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. High-Plex
9.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Gene Expression Market, By Technique Type
10.1. Gene Expression Market, by Technique Type , 2020-2030
10.1.1. RNA Exp.
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Promoter Analysis
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Protein Exp. & Posttranslational Modification Analysis
10.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Gene Expression Market, By Application Type
11.1. Gene Expression Market, by Application Type, 2020-2030
11.1.1. Drug Discovery & Development
11.1.1.1. Market Revenue and Forecast (2016-2030)
11.1.2. Clinical Diagnostics
11.1.2.1. Market Revenue and Forecast (2016-2030)
11.1.3. Biotechnology & Microbiology
11.1.3.1. Market Revenue and Forecast (2016-2030)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 12. Global Gene Expression Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.1.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.1.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.1.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.1.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.1.6.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.1.6.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.1.6.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.1.7. Market Revenue and Forecast, by Application Type (2016-2030)
12.1.8. Rest of North America
12.1.8.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.1.8.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.1.8.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.1.8.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.1.8.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.2.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.2.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.2.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.2.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.2.6.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.2.6.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.2.7. Market Revenue and Forecast, by Technique Type (2016-2030)
12.2.8. Market Revenue and Forecast, by Application Type (2016-2030)
12.2.9. Germany
12.2.9.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.2.9.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.2.9.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.2.10. Market Revenue and Forecast, by Technique Type (2016-2030)
12.2.11. Market Revenue and Forecast, by Application Type (2016-2030)
12.2.12. France
12.2.12.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.2.12.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.2.12.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.2.12.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.2.13. Market Revenue and Forecast, by Application Type (2016-2030)
12.2.14. Rest of Europe
12.2.14.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.2.14.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.2.14.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.2.14.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.2.15. Market Revenue and Forecast, by Application Type (2016-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.3.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.3.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.3.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.3.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.3.6.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.3.6.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.3.6.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.3.7. Market Revenue and Forecast, by Application Type (2016-2030)
12.3.8. China
12.3.8.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.3.8.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.3.8.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.3.8.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.3.9. Market Revenue and Forecast, by Application Type (2016-2030)
12.3.10. Japan
12.3.10.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.3.10.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.3.10.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.3.10.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.3.10.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.3.11. Rest of APAC
12.3.11.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.3.11.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.3.11.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.3.11.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.3.11.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.4.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.4.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.4.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.4.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.4.6.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.4.6.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.4.6.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.4.7. Market Revenue and Forecast, by Application Type (2016-2030)
12.4.8. North Africa
12.4.8.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.4.8.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.4.8.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.4.8.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.4.9. Market Revenue and Forecast, by Application Type (2016-2030)
12.4.10. South Africa
12.4.10.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.4.10.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.4.10.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.4.10.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.4.10.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.4.11. Rest of MEA
12.4.11.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.4.11.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.4.11.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.4.11.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.4.11.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.5.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.5.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.5.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.5.5. Market Revenue and Forecast, by Application Type (2016-2030)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.5.6.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.5.6.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.5.6.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.5.7. Market Revenue and Forecast, by Application Type (2016-2030)
12.5.8. Rest of LATAM
12.5.8.1. Market Revenue and Forecast, by Process Type (2016-2030)
12.5.8.2. Market Revenue and Forecast, by Product Type (2016-2030)
12.5.8.3. Market Revenue and Forecast, by Capacity Type (2016-2030)
12.5.8.4. Market Revenue and Forecast, by Technique Type (2016-2030)
12.5.8.5. Market Revenue and Forecast, by Application Type (2016-2030)
Chapter 13. Company Profiles
13.1. QIAGEN
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Quest Diagnostics, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. F. Hoffmann-La Roche Ltd.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Illumina, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. PerkinElmer, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Bio-Rad Laboratories
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Thermo Fisher Scientific, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Agilent Technologies
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GE Healthcare
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Promega Corp.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
13.11. Luminex Corp.
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance
13.11.4. Recent Initiatives
13.12. Takara Bio, Inc.
13.12.1. Company Overview
13.12.2. Product Offerings
13.12.3. Financial Performance
13.12.4. Recent Initiatives
13.13. Danaher Corp.
13.13.1. Company Overview
13.13.2. Product Offerings
13.13.3. Financial Performance
13.13.4. Recent Initiatives
13.14. ELITechGroup
13.14.1. Company Overview
13.14.2. Product Offerings
13.14.3. Financial Performance
13.14.4. Recent Initiatives
13.15. AutoGenomics
13.15.1. Company Overview
13.15.2. Product Offerings
13.15.3. Financial Performance
13.16. Biocartis NV
13.16.1. Company Overview
13.16.2. Product Offerings
13.16.3. Financial Performance
13.17. IntegraGen
13.17.1. Company Overview
13.17.2. Product Offerings
13.17.3. Financial Performance
13.18. Interpace Biosciences, Inc.
13.18.1. Company Overview
13.18.2. Product Offerings
13.18.3. Financial Performance
13.19. Fluidigm Corp.
13.19.1. Company Overview
13.19.2. Product Offerings
13.19.3. Financial Performance
13.19.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms